Search Results Search Sort by RelevanceMost Recent Podcast May 2019 Ethics Talk: When and How Should ECMO Be Initiated and Removed? When should ECMO be started and stopped? This month’s Ethics Talk explores ethical challenges of ECMO use in end-of-life care. Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852. Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575. AMA Code Says Jul 2019 AMA Code of Medical Ethics’ Opinions Related to Unrepresented Patients Danielle Hahn Chaet, MSB The AMA Code of Medical Ethics discusses situations in which a surrogate is needed but not available to make health care decisions for a patient. AMA J Ethics. 2019;21(7):E600-602. doi: 10.1001/amajethics.2019.600. In the Literature Apr 2016 A Defense of “The Case for Conserving Disability” Jasmine Zahid Rosemarie Garland-Thomson’s argument for disability as a sociocultural resource challenges the commonsense understanding of disability as a deficit. AMA J Ethics. 2016;18(4):399-405. doi: 10.1001/journalofethics.2016.18.4.nlit2-1604. Viewpoint Dec 2002 The Twelve Days of Christmas Audiey Kao, MD, PhD Virtual Mentor. 2002;4(12):370-371. doi: 10.1001/virtualmentor.2002.4.12.dykn1-0212. Viewpoint Jan 2006 Is Prenatal Genetic Screening Unjustly Discriminatory? Jeff McMahan, PhD Virtual Mentor. 2006;8(1):50-52. doi: 10.1001/virtualmentor.2006.8.1.oped1-0601. Viewpoint Jan 2006 The Uncertain Rationale for Prenatal Disability Screening David Wasserman, JD and Adrienne Asch, PhD Virtual Mentor. 2006;8(1):53-56. doi: 10.1001/virtualmentor.2006.8.1.oped2-0601. Medical Education Aug 2006 Funding of Dermatology Residencies by the Pharmaceutical and Medical Device Industries: What Are the Ethical Ramifications? Michael J. Franzblau, MD Virtual Mentor. 2006;8(8):512-513. doi: 10.1001/virtualmentor.2006.8.8.medu2-0608. Medical Education May 2009 Medical Business Ethics Education: Guarding the Patient-Centered Focus of Medicine James M. DuBois, PhD, DSc Virtual Mentor. 2009;11(5):373-377. doi: 10.1001/virtualmentor.2009.11.5.medu1-0905. Pagination Current page 1 Page 2 Next page Next › Last page Last »
Podcast May 2019 Ethics Talk: When and How Should ECMO Be Initiated and Removed? When should ECMO be started and stopped? This month’s Ethics Talk explores ethical challenges of ECMO use in end-of-life care.
Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852.
Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575.
AMA Code Says Jul 2019 AMA Code of Medical Ethics’ Opinions Related to Unrepresented Patients Danielle Hahn Chaet, MSB The AMA Code of Medical Ethics discusses situations in which a surrogate is needed but not available to make health care decisions for a patient. AMA J Ethics. 2019;21(7):E600-602. doi: 10.1001/amajethics.2019.600.
In the Literature Apr 2016 A Defense of “The Case for Conserving Disability” Jasmine Zahid Rosemarie Garland-Thomson’s argument for disability as a sociocultural resource challenges the commonsense understanding of disability as a deficit. AMA J Ethics. 2016;18(4):399-405. doi: 10.1001/journalofethics.2016.18.4.nlit2-1604.
Viewpoint Dec 2002 The Twelve Days of Christmas Audiey Kao, MD, PhD Virtual Mentor. 2002;4(12):370-371. doi: 10.1001/virtualmentor.2002.4.12.dykn1-0212.
Viewpoint Jan 2006 Is Prenatal Genetic Screening Unjustly Discriminatory? Jeff McMahan, PhD Virtual Mentor. 2006;8(1):50-52. doi: 10.1001/virtualmentor.2006.8.1.oped1-0601.
Viewpoint Jan 2006 The Uncertain Rationale for Prenatal Disability Screening David Wasserman, JD and Adrienne Asch, PhD Virtual Mentor. 2006;8(1):53-56. doi: 10.1001/virtualmentor.2006.8.1.oped2-0601.
Medical Education Aug 2006 Funding of Dermatology Residencies by the Pharmaceutical and Medical Device Industries: What Are the Ethical Ramifications? Michael J. Franzblau, MD Virtual Mentor. 2006;8(8):512-513. doi: 10.1001/virtualmentor.2006.8.8.medu2-0608.
Medical Education May 2009 Medical Business Ethics Education: Guarding the Patient-Centered Focus of Medicine James M. DuBois, PhD, DSc Virtual Mentor. 2009;11(5):373-377. doi: 10.1001/virtualmentor.2009.11.5.medu1-0905.